CASE DISCUSSION
Novel Biomarkers in Sepsis
Presented from United Arab Emirates by Dr. Adel Mohamed Yasin Al SisiViews
4,752
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Elevated levels of PCT serve as a valuable biomarker in sepsis, aiding in the early diagnosis and monitoring of bacterial infections, and guiding therapeutic decisions. CRP is a commonly used biomarker for inflammation, and its levels are frequently elevated in sepsis, providing clinicians with an...
Case Summary
- Sepsis definition has evolved, moving from SIRS criteria to a dysregulated immune response to infection leading to organ dysfunction. Early identification and immediate action are crucial, focusing on the first hour after suspected sepsis, emphasizing clinical assessment, blood tests, and organ support. Clinical evaluation remains critical, along with laboratory tests and organ function support, highlighting the importance of early management and risk stratification.
Speaker Profile
Dr. Adel Mohamed Yasin Al Sisi
Critical care Specialist, Prime Hospitals, DubaiDr. Adel Mohamed Yasin Al Sisi is currently working as Chief Medical Officer at Prime Healthcare Group and the Chair of the Intensive Care Unit. He completed his MBBS from Cairo University’s Faculty of Medicine and earned a Master’s Degree in Critical Care Medicine. He further achieved a Ph.D. in Critical Care Medicine, completed Sequential Trauma Education Programs (STEPs) from the University of Maryland and Ain Shams University, Egypt, and an Aeromedical Evacuation Course under the Egyptian College of Critical Care Physicians (ECCP)